Incubation period of hantavirus cardiopulmonary syndrome.

作者信息

Vial Pablo A, Valdivieso Francisca, Mertz Gregory, Castillo Constanza, Belmar Edith, Delgado Iris, Tapia Mauricio, Ferrés Marcela

机构信息

Faculdad se Medicina Clinica Alemana, Universidad del Desarrollo, Las Condes 12438, Lo Barnechea, Santiago 0000, Chile.

出版信息

Emerg Infect Dis. 2006 Aug;12(8):1271-3. doi: 10.3201/eid1208.051127.

DOI:10.3201/eid1208.051127

PMID:16965713

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3291207/

Abstract

The potential incubation period from exposure to onset of symptoms was 7-39 days (median 18 days) in 20 patients with a defined period of exposure to Andes virus in a high-risk area. This period was 14-32 days (median 18 days) in 11 patients with exposure for <48 hours.

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/3291207/6adfd02f1a09/05-1127-F.jpg

相似文献

Incubation period of hantavirus cardiopulmonary syndrome.

Emerg Infect Dis. 2006 Aug;12(8):1271-3. doi: 10.3201/eid1208.051127.

Hantavirus pulmonary syndrome: encephalitis caused by virus Andes.

J Neurovirol. 2011 Apr;17(2):189-92. doi: 10.1007/s13365-010-0011-4. Epub 2011 Jan 15.

Hantavirus pulmonary syndrome: the sound of a mouse roaring.

J Infect Dis. 2007 Jun 1;195(11):1553-5. doi: 10.1086/516793. Epub 2007 Apr 16.

[Hantavirus pulmonary syndrome].

Nihon Naika Gakkai Zasshi. 2004 Nov 10;93(11):2347-50. doi: 10.2169/naika.93.2347.

A 19 Year Analysis of Small Mammals Associated with Human Hantavirus Cases in Chile.

Viruses. 2019 Sep 12;11(9):848. doi: 10.3390/v11090848.

The incubation period of hantavirus pulmonary syndrome.

Am J Trop Med Hyg. 2000 Jun;62(6):714-7. doi: 10.4269/ajtmh.2000.62.714.

Pathogenic hantaviruses, northeastern Argentina and eastern Paraguay.

Emerg Infect Dis. 2007 Aug;13(8):1211-4. doi: 10.3201/eid1308.061090.

[Hantapulmonary syndrome].

Zh Mikrobiol Epidemiol Immunobiol. 2012 Jan-Feb(1):101-7.

Andes Hantavirus as possible cause of disease in travellers to South America.

Travel Med Infect Dis. 2007 Jan;5(1):30-4. doi: 10.1016/j.tmaid.2006.02.002. Epub 2006 May 15.

Hantavirus pulmonary syndrome: at the crossroads.

Curr Opin Infect Dis. 2001 Apr;14(2):205-9. doi: 10.1097/00001432-200104000-00016.

引用本文的文献

Beyond ECMO Survival: Long-Term Symptom Burden and Quality-of-Life Impairment in Hantavirus Cardiopulmonary Syndrome Survivors.

Viruses. 2025 Sep 15;17(9):1241. doi: 10.3390/v17091241.

Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study.

Lancet Infect Dis. 2024 Jul;24(7):775-782. doi: 10.1016/S1473-3099(24)00142-7. Epub 2024 Apr 3.

Case of Human Orthohantavirus Infection, Michigan, USA, 2021.

Emerg Infect Dis. 2024 Apr;30(4):817-821. doi: 10.3201/eid3004.231138.

Presence and Persistence of Andes Virus RNA in Human Semen.

Viruses. 2023 Nov 17;15(11):2266. doi: 10.3390/v15112266.

Emerging Maripa Hantavirus as a Potential Cause of a Severe Health Threat in French Guiana.

Am J Trop Med Hyg. 2023 Mar 13;108(5):1014-1016. doi: 10.4269/ajtmh.22-0390. Print 2023 May 3.

Hantavirus Cardiopulmonary Syndrome and Diffuse Alveolar Hemorrhage in the Era of COVID-19.

Case Rep Infect Dis. 2021 Sep 24;2021:8800500. doi: 10.1155/2021/8800500. eCollection 2021.

Serological Evidence of Human Orthohantavirus Infections in Barbados, 2008 to 2016.

Pathogens. 2021 May 8;10(5):571. doi: 10.3390/pathogens10050571.

Targeted high volume hemofiltration could avoid extracorporeal membrane oxygenation in some patients with severe Hantavirus cardiopulmonary syndrome.

J Med Virol. 2021 Aug;93(8):4738-4747. doi: 10.1002/jmv.26930. Epub 2021 Mar 23.

Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Immunology. 2021 Jul;163(3):262-277. doi: 10.1111/imm.13322. Epub 2021 Mar 18.

Novel therapeutic approaches toward virus and its clinical features' similarity with COVID-19.

Indian J Pharmacol. 2020 Sep-Oct;52(5):347-355. doi: 10.4103/ijp.ijp_1001_20.

本文引用的文献

Three-week incubation period for hantavirus infection.

Pediatr Infect Dis J. 2004 Oct;23(10):974-5. doi: 10.1097/01.inf.0000142011.98248.15.

Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.

Clin Infect Dis. 2004 Nov 1;39(9):1307-13. doi: 10.1086/425007. Epub 2004 Oct 11.

Hantavirus pulmonary syndrome in Latin America.

Curr Opin Infect Dis. 2004 Oct;17(5):427-31. doi: 10.1097/00001432-200410000-00007.

Peridomestic small mammals associated with confirmed cases of human hantavirus disease in southcentral Chile.

Am J Trop Med Hyg. 2004 Mar;70(3):305-9.

Hemorrhagic fever: a study of 300 cases.

Medicine (Baltimore). 1954 May;33(2):97-153.

Shedding and intracage transmission of Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus) model.

J Virol. 2002 Aug;76(15):7587-94. doi: 10.1128/jvi.76.15.7587-7594.2002.

The incubation period of hantavirus pulmonary syndrome.

Am J Trop Med Hyg. 2000 Jun;62(6):714-7. doi: 10.4269/ajtmh.2000.62.714.

Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus.

Virology. 1998 Feb 15;241(2):323-30. doi: 10.1006/viro.1997.8976.

An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia.

Emerg Infect Dis. 1997 Apr-Jun;3(2):171-4. doi: 10.3201/eid0302.970210.

Hantaviruses: a global disease problem.

Emerg Infect Dis. 1997 Apr-Jun;3(2):95-104. doi: 10.3201/eid0302.970202.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验